Depomed Fingers Lupin In Diabetes Drug Patent Case
Depomed Inc. has accused generic-drug maker Lupin Ltd. of infringing four patents for control-release drug delivery technology used in the specialty pharmaceutical company's type 2 diabetes drug Glumetza....To view the full article, register now.
Already a subscriber? Click here to view full article